UnknownPhase 2/3

Peripheral Venous Catheter Trial: 3 Day Versus No Routine Change

Australia200 participantsStarted 2004-03

Plain-language summary

The purpose of this study is to investigate the effects of extending the dwell time of peripheral intravenous cannulas on clinical outcomes and cost.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Patients are eligible to join the Peripheral Venous Catheter Trial if: * They are inpatients at the Royal Brisbane and Royal Women's Hospital who are at least 18 years of age AND * They are scheduled or expected to have a peripheral venous catheter indwelling for at least 4 days. AND * They have had their catheter inserted by a nurse from the IV Therapy Team Exclusion Criteria: * Patients with an existing bloodstream infection * Those receiving immunosuppressive treatment

What they're measuring

Phlebitis during the course of the infusion and up to 48 hours after peripheral venous catheter removal

Trial details

NCT IDNCT00103636

SponsorRoyal Brisbane and Women's Hospital

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Phlebitis trials